𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In Reply to ‘Rituximab and B-Cell Return in ANCA-Associated Vasculitis’

✍ Scribed by Kallenberg, Cees G.M.; Stegeman, Coen A.; Abdulahad, Wayel H.; Heeringa, Peter

Book ID
124124145
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
109 KB
Volume
63
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab versus Cyclophosphamide in ANC
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
✍ Jones, Rachel B.; Cohen Tervaert, Jan Willem; Hauser, Thomas; Luqmani, Raashid; 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 408 KB

## Background: Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody (anca)-associated vasculitis are effective in 70 to 90% of patients, but they are associated with high rates of death and adverse events. treatment with rituximab has led to remission rates of 80 to 90% among